Deletion of IP6K1 in the apoA-I null mice failed to augment cholesterol efflux (Fig. 6J), and did not alleviate atherosclerosis (Fig. 6K, L), confirming that the atheroprotective effects of hepatocyte-specific IP6K1 deletion require apoA-I. This evidence concerns the gene IP6K1 and atherosclerosis.